Evidence map›Paper›PMID 16537431›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.

Camila Guindalini, Mark Howard, Kate Haddley, Ronaldo Laranjeira, David Collier, Nik Ammar, Ian Craig, Colin O'Gara, Vivian J Bubb, Tiffany Greenwood and 7 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 2 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 2 syntheses or guidelines pooled it, 176 citations in OpenAlex.

  1. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2010
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. PGx-BasedCurrent neuropharmacology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Non-coding genetic variation shaping mental health.Current opinion in psychology · 2019
    Review
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Camila GuindaliniMedical Research Council Social Genetic and Developmental Psychiatry Research Centre, Division of Psychological Medicine, Institute of Psychiatry, King's College London, London SE5 8AF, United Kingdom.
Mark Howard
Kate Haddley
Ronaldo Laranjeira
David Collier
Nik Ammar
Ian Craig
Colin O'Gara
Vivian J Bubb
Tiffany Greenwood
John Kelsoe
Phil Asherson
Robin M Murray
Adauto Castelo
John P Quinn
Homero Vallada
Gerome Breen
Medical Research Council · GBUniversity of Liverpool · GBUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BRKing's College London · GBUniversity of California, San Diego · USVA San Diego Healthcare System · US

Funding

Medical Research Council G0701003Medical Research Council G90/106
6 · The paper itself

Abstract

The dopamine (DA) transporter DAT1 is a major target bound by cocaine in brain. We examined the influence of functional genetic variants in DAT1 on cocaine addiction. Repeat polymorphisms, including a 30-bp variable-number tandem repeat (VNTR) in intron 8 (Int8 VNTR) with two common alleles, were genotyped in cocaine-dependent abusers (n = 699) and in controls with no past history of drug abuse (n = 866) from São Paulo, Brazil. Positive association was observed with allele 3 of the Int8 VNTR and cocaine abuse (allele odds ratio = 1.2, 95% confidence interval = 1.01-1.37, P = 0.036; 3/3 homozygote odds ratio = 1.45, 95% confidence interval = 1.18-1.78, P = 0.0008). Population stratification was assessed and did not affect the results. Haplotypic analyses using additional polymorphisms indicated that the Int8 VNTR is responsible for the observed association. Functional analyses in reporter-gene constructs, demonstrated that allele 3 mediates significant (P < 0.05) but small reduced expression compared with the "protective" allele 2. This difference increased when 1 and 10 muM cocaine was added to the cell culture ( approximately 40% reduction of the 3 allele expression versus the 2 allele). The 3 allele also demonstrated approximately 3-fold-increased expression over the 2 allele in response to KCl plus forskolin challenge. We demonstrate a robust association between cocaine dependence and a VNTR allele in SLC6A3, conferring a small but detectable effect, and we show that this VNTR may be functional. This study suggests that DAT1 gene variation may play a role in cocaine dependence etiology.

Indexed as

Polymorphism, GeneticAdolescentAdultAllelesBrazilCocaine-Related DisordersDopamine Plasma Membrane Transport ProteinsFemaleGene FrequencyGenetic MarkersGenotypeHaplotypesHumansIntronsMaleMinisatellite RepeatsDopamine Plasma Membrane Transport ProteinsGenetic MarkersSLC6A3 protein, human

Identifiers

PMID16537431
PMCPMC1450209
OpenAlexW1994661693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.